Clinical efficacy of codergocrine mesylate in children with learning difficulties.

A double-blind placebo-controlled study in children showed codergocrine mesylate to be effective in improving cognitive functions and behavioural symptoms associated with learning disorders. Forty randomly grouped children of either sex were given an increasing dosage of codergocrine mesylate and followed up for 12 weeks. A significant improvement was noted in speech (acquisition of new words, comprehensibility/meaningfulness of speech), sociability, attention/concentration, comprehension and memory. Improvement in behaviour (emotional lability and cooperativeness) was also noted. Problems of assessing cognitive progress in very young children with culturally appropriate methods were encountered.
AuthorsK I Tareen, A Bashir, K Saeed, T Hussain
JournalThe Journal of international medical research (J Int Med Res) 1988 May-Jun Vol. 16 Issue 3 Pg. 204-9 ISSN: 0300-0605 [Print] ENGLAND
PMID3044872 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Dihydroergotoxine
  • Adolescent
  • Attention (drug effects)
  • Child
  • Child Behavior (drug effects)
  • Clinical Trials as Topic
  • Dihydroergotoxine (therapeutic use)
  • Female
  • Humans
  • Learning Disorders (drug therapy, psychology)
  • Male
  • Rhinitis (chemically induced)
  • Social Behavior
  • Speech Intelligibility (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: